Skip to content
Wholesale trade
KZActiveBIN 120840008018
Plans from 2 000 ₸ a month
No entries in risk registers
Registers checked: 18
To risks

ТОО "THE PHARMА NETWORK" (ЗЭ ФАРМА НЭТВОРК)

Director
Парикх Виралкумар Гиришкумар
Incorporated
16.08.2012
Address
Алматы пр. АЛЬ-ФАРАБИ, 13, Н.П. 66А
РНН
600700667748

This is a company preview

Unlock the full report for 1 check — contacts, bank accounts, court cases, government contracts, arrests, licenses and PDF export.

The pack is not a subscription, its checks last 30 days

Risks

0/18

This assessment is informational and analytical only, based on our internal methodology and open sources; it is not an official government conclusion or a guarantee of reliability.

Procurement signals

Court cases

Arrests & encumbrances

Enforcement proceedings

Certificates

Licenses and permits

Profile

Summary

Full name
ТОВАРИЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "THE PHARMА NETWORK" (ЗЭ ФАРМА НЭТВОРК)
BIN
120840008018
Status
Active
Director
Парикх Виралкумар Гиришкумар
Registration date
16.08.2012
Activity
Оптовая торговля фармацевтическими товарами, кроме торговли медицинской техникой и ортопедическими изделиями
Legal address
Алматы пр. АЛЬ-ФАРАБИ, 13, Н.П. 66А
VAT payer
Yes, since 12.04.2024
КАТО
751410000
РНН
600700667748
КФС
Собственность иностранных юридических лиц
КСЕ
Нефинансовые корпорации под иностранным контролем – ОПП
Company size
Малые предприятия
Employees
от 51 до 100 чел.

Has changed

Procurement role
Поставщик

Activities

1
46461primary

Оптовая торговля фармацевтическими товарами, кроме торговли медицинской техникой и ортопедическими изделиями

Download

Contacts

Change history

Financials

Tax payments

6

By year · ₸

2026
443.2M
2025
422.9M+75%
2024
241.5M+71%
2023
141.5M+11%
2022
127M+333%
2021
29.3M
·443.2M
2026year to date
+75%422.9M
2025
+71%241.5M
2024
+11%141.5M
2023
+333%127M
2022
·29.3M
2021
2026
Tax paid443,218,473 ₸
Penalty303,066 ₸
Fine0 ₸
VAT refund0 ₸
2025
Tax paid422,853,119 ₸
Penalty8,200 ₸
Fine5,537,732 ₸
VAT refund0 ₸
2024
Tax paid241,483,588 ₸
Penalty12,700 ₸
Fine0 ₸
VAT refund0 ₸
2023
Tax paid141,530,071 ₸
Penalty456,500 ₸
Fine0 ₸
VAT refund0 ₸
2022
Tax paid126,953,764 ₸
Penalty39,500 ₸
Fine1,220,970 ₸
VAT refund0 ₸
2021
Tax paid29,323,153 ₸
Penalty230 ₸
Fine0 ₸
VAT refund0 ₸
Estimated taxable profit

Estimate: corporate income tax ÷ 0%. Not a filing and not revenue — the taxable profit implied by the corporate income tax paid. Actual profit differs by deductions, carried-forward losses and reduced rates.

Download

Financial statements

Premium

Public contracts

What it sells and where

Samruk-Kazyna procurement

Tender bids

Procurement as a customer

Assets

Bank accounts

Management & owners

Leadership

1
  • ПВ

    Парикх Виралкумар Гиришкумар

    Director

Download

Founders

Accreditations

Employees

Affiliated companies

Premium

Director's involvement in other legal entities

Branches

Relations & mentions

Company networks

Premium

Similar companies

Media mentions

Company summary

ТОО "THE PHARMА NETWORK" (ЗЭ ФАРМА НЭТВОРК) (BIN 120840008018) is an active legal entity in Алматы, registered in 2012 (14 years on the market). Primary activity — оптовая торговля фармацевтическими товарами, кроме торговли медицинской техникой и ортопедическими изделиями. Per open government registries as of November 9, 2026: 23 government contracts on Портал государственных закупок РК (goszakup.gov.kz) worth 15,747,406 ₸. Automated screening of open registries found no risk indicators for "THE PHARMА NETWORK". Director on record — Парикх Виралкумар Гиришкумар. Data current as of November 9, 2026.

Information is aggregated from open government registries of Kazakhstan: Министерство юстиции РК, Комитет государственных доходов МФ РК, Верховный Суд РК, Портал государственных закупок РК, АО «Самрук-Казына», Бюро национальной статистики РК, Портал электронного лицензирования. Data is indexed automatically and may lag behind primary sources; the absence of a record does not guarantee the absence of the corresponding facts. This is reference information and does not replace an official extract. Learn more about the methodology and sources — SafeDeal editorial policy.